|
Volumn 30, Issue 5, 1999, Pages 956-961
|
EASL International Consensus Conference on Hepatitis C, Paris, 26-28 February 1999: Consensus Statement
a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS C VACCINE;
INTERFERON;
RIBAVIRIN;
CONFERENCE PAPER;
DIAGNOSTIC APPROACH ROUTE;
DISEASE COURSE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EUROPE;
HEPATITIS C;
HUMAN;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK FACTOR;
SCREENING TEST;
SOCIAL ASPECT;
TREATMENT PLANNING;
|
EID: 0033054813
PISSN: 01688278
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-8278(99)80154-8 Document Type: Conference Paper |
Times cited : (797)
|
References (0)
|